Objectionable Microorganisms: Considering the Risk

This webinar on objectionable microorganisms will explore the most current practices that define an objectionable microorganism and will provide a practical approach to determining just how objectionable it really is.

Why Should You Attend:

Due to increased scrutiny by the FDA and other regulatory agencies, companies must now determine how to reduce the risk if they find objectionable microorganisms. This webinar will provide an expert's insight into reducing this risk.

Who Will Benefit:

All FDA regulated companies will benefit from this webinar - pharmaceutical, biotech, medical device companies and laboratories.

Quality system auditors

QA directors and managers

Information technology managers and personnel

Microbiology analysts and technicians

Instructor Profile:

Henry Urbach is a founder of GMP Training, Development and Consulting (GMP TDC) LLC, a New York-based consulting organization serving life sciences industries. He has over 20 years of life sciences experience having held positions of increased responsibility in training, QA, and QC microbiology. His experience includes managing GMP compliance and quality systems training, implementing a training program as part of a post-regulatory action remediation, and developing an environmental monitoring training program.

Note:

Use coupon code NB5SQH8N and get 10% off on registration, Valid till Dec 31st 2015.

For Registration:

http://www.complianceonline.com/defining-and-determining-objectionable-microorganisms-risk-practical-approaches-webinar-training-702964-prdw?channel=sciencedz